Equity Overview
Price & Market Data
Price: $9.70
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $527,873,824
Daily Volume: 0
Performance Metrics
1 Week: 10.48%
1 Month: 26.63%
3 Months: -62.88%
6 Months: -47.93%
1 Year: 52.52%
YTD: -64.27%
Company Details
Employees: 75
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.